
|Videos|March 27, 2015
Lymph Node Dissection in Bladder Cancer
Advertisement
For High-Definition, Click
The number of lymph nodes removed from individuals with muscle-invasive bladder cancer is being used as a surrogate measure for the quality of the dissection, says Dean F. Bajorin, MD. There are studies looking at defining a dissection up to the bifurcation of the iliacs versus up to the bifurcation of the aorta, and whether greater or extended lymph node dissection makes a difference.
It is important to standardize the way the procedure is performed to maintain consistency from institution to institution. Ongoing clinical trials are assessing how a dissection should be defined, including the definitions of standard dissection and extended dissection.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
3
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
4
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
5



































